Qiagen N.V. (QGEN) Launches QIAseq xHYB Panels for Long-Read Sequencing [Yahoo! Finance]
Qiagen N.V. Common Shares (QGEN)
Last qiagen n.v. common shares earnings: 2/4 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
corporate.qiagen.com/investor-relations
Company Research
Source: Yahoo! Finance
Qiagen N.V. (NYSE:QGEN), a global leader in molecular diagnostics and sample preparation technologies, continues to advance its position in clinical laboratories, biopharmaceuticals, and life science research. Headquartered in the Netherlands and operating in over 30 countries under CEO Thierry Bernard, the company provides a wide range of solutions, including nucleic acid extraction systems, PCR reagents, digital PCR platforms, next-generation sequencing kits, and proteomics tools. The company stands seventh on our list among the hot stocks to buy In Q2 2025, Qiagen N.V. (NYSE:QGEN) reported net sales of $534 million, marking a 7% increase from the prior year, with an adjusted operating income margin of 29.9%, up 1.5 percentage points. Growth was fueled by strong demand for products such as QIAstat-Dx, which grew 41% CER, and QuantiFERON, which increased 11% CER. Reflecting confidence in its operational momentum, the business raised its full-year 2025 net sales growth outlook to 4
Show less
Read more
Impact Snapshot
Event Time:
QGEN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
QGEN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
QGEN alerts
High impacting Qiagen N.V. Common Shares news events
Weekly update
A roundup of the hottest topics
QGEN
News
- Qiagen (NYSE:QGEN) had its "hold (c)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Qiagen (NYSE:QGEN) had its "hold (c)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Should You Continue to Hold Hologic Stock Post Q4 Earnings? [Yahoo! Finance]Yahoo! Finance
- QIAGEN Unveils QIAsymphony Connect and Showcases New Precision Oncology Innovations at AMP 2025Business Wire
- QIAGEN Exceeds Q3 2025 Outlook, Raises FY 2025 Adj. EPS Target, Announces Parse Acquisition and $500 Million Share RepurchaseBusiness Wire
QGEN
Earnings
- 11/4/25 - Beat
QGEN
Sec Filings
- 11/12/25 - Form SCHEDULE
- 11/6/25 - Form 6-K
- 11/6/25 - Form 6-K
- QGEN's page on the SEC website